Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Labels & regulation

Veterinary quasi-drugs in South Korea: what they are

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Veterinary quasi-drugs in South Korea: what they are
Short answer

In South Korea, veterinary quasi-drugs are a category set by the Pharmaceutical Affairs Act and the Rules on the Handling of Veterinary Drugs, etc., with the scope listed in an Animal and Plant Quarantine Agency public notice. Disinfectants, pest control agents, mouth and ear cleaners and shampoos are on the notice's list.

Key takeaways

  • In Korea, a veterinary quasi-drug is a category separate from veterinary drugs, set by Article 2, paragraph 1, item 3 of the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙), and the head of the Animal and Plant Quarantine Agency (APQA) decides by public notice which articles fall under it.
  • Appendix Table 1 of the public notice, the Regulation on the Scope and Designation of Veterinary Quasi-drugs (동물용의약외품의 범위 및 지정 등에 관한 규정), lists 10 items, including disinfectants, pest control, preventive and repellent agents, mouth, ear and eye cleaners, deodorants, medicated shampoos, teat dips and oral nutritional supplements.
  • In Appendix Table 1, the same notice does not treat as veterinary quasi-drugs the nutritional supplements registered under the Control of Livestock and Fish Feed Act (사료관리법) or the supplementary feed additives registered as supplementary feed, which fixes the boundary with feed.
  • The quasi-drug category does not by itself mean a product is safe or has proven effects. Article 68 of the Pharmaceutical Affairs Act (약사법) allows advertising only after approval or notification, and prohibits false or exaggerated advertising and advertising that hints at efficacy.
  • The package must carry the words veterinary quasi-drug together with the efficacy and effects, precautions and so on, so when choosing a product, check those words and the approval or notification details first, and take an animal with any abnormality to an animal hospital.

The conclusion first: veterinary quasi-drugs are a category the law sets apart, between medicines and ordinary goods

In Korea, a veterinary quasi-drug is a category of article used on animals that the Pharmaceutical Affairs Act (약사법) and the rules under it group as a branch separate from medicines. Article 2, paragraph 1, item 3 of the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) (hereafter the Handling Rules) divides veterinary quasi-drugs into 2 types. Sub-item (a) covers pet preparations such as mouth fresheners, cleaners and deodorants, disinfectants for animal disease prevention, pest control agents, and vitamin preparations as nutritional supplements, that is, products whose action on animals is slight or not direct and that are not instruments or machines, and anything similar. Sub-item (b) covers textile and rubber products used to treat, alleviate, manage or prevent animal disease, and anything similar. Both are subject to the condition that they are what the head of the APQA or the Commissioner of the National Fishery Products Quality Management Service sets by public notice.

So whether a product is a veterinary quasi-drug is decided not by the product's advertising wording but by the list in the public notice and the approval or notification the product received. This article does not explain how to choose or give a medicine. It explains, from the text of the articles and the public notice, what this category is, which products fall under it, and under what procedures and labeling rules they reach the market. It does not recommend or compare specific products, and to avoid overlapping with other articles in the same room, on the legal comparison of supplements and medicines and on feed labeling, it concentrates on the system itself.

This article is an editorial draft that has not had specialist veterinary or pharmacist review. Laws and public notices change, so read it as the content as opened on November 22, 2026.

How does the Pharmaceutical Affairs Act define quasi-drugs, and what is the special rule for animal use?

Article 2, item 7 of the Pharmaceutical Affairs Act (약사법) defines a quasi-drug (醫藥外品) as an article that falls under one of 3 types and that is designated by the Minister of Food and Drug Safety. Sub-item (a) is a textile or rubber product, or anything similar, used to treat, alleviate, manage or prevent disease in people or animals; sub-item (b) is something whose action on the human body is weak or that does not act directly on the human body, that is not an instrument or machine, and anything similar; and sub-item (c) is a preparation used for sterilization, insect killing and similar uses to prevent infectious disease. The provision carries a parenthesis excluding articles used for the purposes in item 4, sub-item (b) or (c), that is, the diagnosis, treatment, alleviation, management or prevention of disease, or the purpose of exerting a pharmacological effect on structure and function.

The special rule for animal use is in Article 85, paragraph 1 of the Pharmaceutical Affairs Act. It provides that, among matters under the jurisdiction of the Minister of Health and Welfare or the Minister of Food and Drug Safety under this Act, medicines and similar items intended for animal use only fall under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, and that references in the Act to the Minister of Health and Welfare or the Minister of Food and Drug Safety are read as the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries. Article 31, paragraph 6 of the same Act is the paragraph that provides that a manufacturing business license, product approval or product notification may be omitted for medicines or quasi-drugs set by Prime Minister's ordinance, such as medicines for clinical trials (hereafter medicines and similar items), and the term medicines and similar items as used in this Act is defined in the parenthesis of that paragraph. As a result, quasi-drugs for people are handled by the Ministry of Food and Drug Safety, while quasi-drugs used for animals only are handled on the agriculture and food side.

In practice, this jurisdiction goes down one more level. Article 1 of the public notice, the Regulation on the Scope and Designation of Veterinary Quasi-drugs (동물용의약외품의 범위 및 지정 등에 관한 규정), states that the regulation sets the necessary matters on the scope and designation of veterinary quasi-drugs under Article 2, item 7 and Article 85 of the Pharmaceutical Affairs Act and Article 2, paragraph 1, item 3 of the Handling Rules. Article 2-2, paragraph 1 of the Handling Rules places the tasks relating to the manufacture, import and sale of veterinary drugs and veterinary quasi-drugs for livestock, beekeeping, sericulture and pets (excluding ornamental fish), and for combined agricultural and fishery use, under the jurisdiction of the head of the APQA, and those for fisheries only under the Commissioner of the National Fishery Products Quality Management Service.

Which products does the public notice list as veterinary quasi-drugs?

The document that sets the scope is the Animal and Plant Quarantine Agency public notice, the Regulation on the Scope and Designation of Veterinary Quasi-drugs (동물용의약외품의 범위 및 지정 등에 관한 규정). The current text opened at the National Law Information Center on November 22, 2026 is No. 2025-34, a partial amendment in force from December 1, 2025. Article 2, paragraph 1 sets the scope of Article 2, paragraph 1, item 3, sub-item (a) of the Handling Rules in Appendix Table 1, and paragraph 2 sets the types of textile, rubber and paper articles for hygienic use under sub-item (b) of the same item in Appendix Table 2. Article 2, paragraph 3 defines the pets in Appendix Table 1, item 3 as animals kept for companionship under Article 3 of the Enforcement Rule of the Animal Protection Act (동물보호법) (dogs, cats, rabbits, ferrets, guinea pigs and hamsters), and other animals kept not for food but for ornamental or riding purposes and the like.

The table below abridges the 10 items of Appendix Table 1 in wording close to the original. The order and provisos follow the original, and for detailed entries not in the table, the original must be checked directly. Appendix Table 1, item 3, sub-item (b) is marked deleted in the original.

Scope of veterinary quasi-drugs (product groups in Appendix Tables 1 and 2 of the public notice, as of No. 2025-34)
Position in the noticeProduct groupProviso attached in the original
Appendix Table 1, item 1Disinfectants for animal disease prevention: disinfectants used for epidemic prevention on animal bodies (including carcasses), barns and their surroundings, livestock transport vehicles and equipment, waste, drinking water for animals (including water supply pipes), fish, fish farms, livestock equipment and the like, and other disinfectants and sterilizers for animalsNone
Appendix Table 1, item 2Pest control agents, preventive agents, repellents and attractant insecticides for animalsExcludes preparations applied directly to animals that are absorbed into the animal's body and act there
Appendix Table 1, item 3Preparations for pets: oral hygiene preparations such as mouth fresheners, tooth cleaners, toothpaste and plaque disclosing agents; cleaners such as ear cleaners, eye cleaners and around-the-eye cleaners; deodorants; animal behavior attractants such as defecation inducers, licking deterrents and behavior improvers; medicated shampoos for the purpose of preventing fleas, dandruff and ticks; hairball control preparations; and external preparations for preventing hair loss, dyeing and hair removalDeodorants exclude perfumes applied directly to hair or skin. Medicated shampoos exclude those applied directly to an animal's fur and skin for the purpose of treating bacterial skin disease, fungal infection, seborrheic inflammation or wounds
Appendix Table 1, item 4Teat dips for animalsNone
Appendix Table 1, item 5Simple external preparations used for body protection, such as wound-area protectants, joint protectants and hoof protectants for animalsNone
Appendix Table 1, item 6Oral preparations for animals: nutritional supplements (single or compound preparations whose main ingredient is a vitamin, enzyme, probiotic, yeast, organic acid, amino acid, sugar, fatty acid, trace mineral or dietary fiber listed in a veterinary drug official compendium or similar, limited to solid preparations such as feed additives, tablets and capsules, and to liquids), and immune function improvers and physiological function promoters (herbal preparations listed in the Korean Pharmacopoeia herbal medicine (crude drug) specifications or similar)A nutritional supplement registered under the Control of Livestock and Fish Feed Act (사료관리법) is not regarded as a veterinary quasi-drug. Herbal preparations are limited to those not used for the purpose of traditional Korean medicine treatment
Appendix Table 1, item 7Supplementary feed additives: antioxidants, antifungal agents, mycotoxin binders, anti-Salmonella agents and the likeA product registered as supplementary feed under the Control of Livestock and Fish Feed Act (사료관리법) is not regarded as a veterinary quasi-drug
Appendix Table 1, items 8, 9 and 10Semen extenders for animals, external sprays for animals (preparations applied directly to the animal's body for purposes such as drying and deodorizing), and other similar productsPet preparations among the external sprays are excluded
Appendix Table 2Veterinary quasi-drugs (hygiene articles): wrapping materials such as bandages, elastic bandages and plaster bandages, surgical and epidemic-prevention masks and eye patches, gauze, surgical drapes, absorbent cotton, adhesive plasters, tissues for disinfecting animals, bathing products such as cleansing shampoos, rinses, conditioners and treatments, perfumes applied directly to hair or skin, and other similar articlesExcludes cosmetic soap under the Cosmetics Act (solid soap only) among the bathing products

Where does the line fall against medicines, feed and ordinary manufactured goods?

The boundary with medicines comes first from the definition in the Pharmaceutical Affairs Act. Article 2, item 4 of the Pharmaceutical Affairs Act (약사법) treats as a medicine an article, other than an instrument, machine or device, that is used for the purpose of diagnosing, treating, alleviating, managing or preventing disease, or of exerting a pharmacological effect on structure and function. Item 7 contains a parenthesis that removes articles for these purposes from quasi-drugs. The proviso on medicated shampoos in Appendix Table 1, item 3 of the notice touches this structure. A shampoo for the purpose of preventing fleas, dandruff and ticks is a veterinary quasi-drug, but a medicated shampoo applied to fur and skin for the purpose of treating bacterial skin disease, wounds and the like is excluded, so a product whose treatment purpose comes first drops out of this list. Appendix Table 1, item 2 also excludes pest preparations that are absorbed into the body and act there, so a preparation that enters the body and acts is placed outside quasi-drugs in the same way.

The boundary with feed is written directly by the notice. Both item 6, nutritional supplements, and item 7, supplementary feed additives, of Appendix Table 1 carry a proviso that a product registered under the Control of Livestock and Fish Feed Act (사료관리법), or registered as supplementary feed, is not regarded as a veterinary quasi-drug. This means that even within the same family of ingredients, the system with jurisdiction differs depending on whether the product is registered as feed or approved or notified as a veterinary quasi-drug, and a comparison of the two is covered in detail in the room's article on the supplement system.

On the boundary with ordinary manufactured goods, I could not confirm a product-by-product criteria table in the notice and rules opened this time. However, Article 3 of the notice sets a procedure. A person who wants to request a review of whether a product is a veterinary quasi-drug under Article 2, item 7 of the Pharmaceutical Affairs Act and Article 2, paragraph 1, item 3 of the Handling Rules must submit to the head of the APQA data on the product's purpose of use, data on the raw materials and amounts, efficacy and effects, and directions and dose, and data on pharmacological action and specifications. The head of the APQA must review whether the product falls under the category and whether the item can be designated, and notify the applicant within 7 days. That an ambiguous product goes through this review is the extent confirmed in the articles, and other laws relating to chemical products were not opened.

What approval and notification does a product go through to reach the market?

The manufacturing business for quasi-drugs is set by Article 31, paragraph 4 of the Pharmaceutical Affairs Act. A person who wants to manufacture quasi-drugs as a business must equip facilities according to the facility standards set by Presidential decree, file a manufacturing business notification with the Minister of Food and Drug Safety, and obtain product approval or file a product notification for each product. Under the special rule in Article 85, paragraph 1 seen above, for animal use the Minister of Food and Drug Safety is read as the Minister of Agriculture, Food and Rural Affairs. For imports, Article 42, paragraph 1 provides for an import business notification and product approval or notification for each product.

What is approval and what is notification is divided by Article 5 of the Handling Rules. Paragraph 1 lists as veterinary drugs and similar items requiring manufacturing product approval veterinary drugs, and veterinary quasi-drugs that fall under Article 2, paragraph 1, item 3, sub-item (a). However, products announced under paragraph 2, item 3 are removed from the approval requirement. Paragraph 2 lists as subject to manufacturing product notification veterinary quasi-drugs that fall under Article 2, paragraph 1, item 3, sub-item (b), and items that the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries has recognized as having no problem with safety and efficacy and announced, among others. Put simply, the basic rule is approval for sub-item (a) products such as disinfectants and pet preparations, and notification for sub-item (b) products such as textile, rubber and paper articles for hygienic use.

The documents to submit when applying for approval are written in paragraph 3 of the same Article. They include documents on the product name, the amounts of raw materials, properties and manufacturing method, efficacy and effects, directions and dose, packaging unit, storage method, shelf life, precautions, test standards and test methods, documents needed for the review of safety and efficacy, and documents on the manufacturing process. For imports, Article 16 follows the same division. An import product approval application requires a certificate of manufacture issued by the government of the country of production and a certificate of sale issued by the government of the country where the product is approved or registered, and only certificates issued within 2 years of the application date count. Import product notification is set separately in Article 16, paragraph 2, and when approval or notification is received, an approval certificate or notification certificate is issued.

What must the package state, and how far may effects be claimed?

Labeling is set by the Pharmaceutical Affairs Act and the Handling Rules together. Article 65, paragraph 1 of the Pharmaceutical Affairs Act has manufacturers and importers of quasi-drugs state on the container or package the name of the quasi-drug, the business name and address of the manufacturer or importer, the volume or weight, the manufacturing number and the use-by date, the names of all ingredients listed on the product approval certificate and product notification certificate (with the possibility of omitting ingredients set by Prime Minister's ordinance, such as ingredients contained in small amounts), the storage method for products with a set standard, and the words quasi-drug and the like. Article 85, paragraph 1 states that the Prime Minister's ordinance in this provision is read as an ordinance of the Ministry of Agriculture, Food and Rural Affairs or of the Ministry of Oceans and Fisheries for animal use, and Article 42, paragraph 2 of the Handling Rules also treats the items to be stated for veterinary quasi-drugs as those under Article 65, item 8 of the Pharmaceutical Affairs Act.

The direct basis for animal use is Article 42 of the Handling Rules. Paragraph 1 requires that on the container or package and in the accompanying document, a veterinary quasi-drug be marked veterinary quasi-drug in a way distinguishable from other text. Paragraph 2 requires the storage method, withdrawal period, contraindications, precautions and side effects set at the time of product approval, the product category label under paragraph 1, and the efficacy and effects to be stated on the container or package and in the accompanying document. It also sets the labeling of the commissioning party and the manufacturer when the entire manufacturing process is outsourced. Article 43, paragraph 1 requires that, among these, the items in Article 42, paragraph 2, item 1 (the storage method, withdrawal period, contraindications, precautions and side effects set at the time of product approval) be stated clearly, distinguishable from other text and designs on the container, package and accompanying document.

The limit on how effects may be expressed is in Article 68 of the Pharmaceutical Affairs Act. Paragraph 1 prohibits false and exaggerated advertising of the name, manufacturing method, efficacy or performance of medicines and similar items. Paragraph 2 prohibits the use of articles that could be mistaken for a guarantee of efficacy or performance by a physician, dentist, practitioner of traditional Korean medicine, veterinarian or any other person, and paragraph 3 prohibits articles, photographs, designs and other suggestive methods that hint at efficacy or performance. Paragraph 5 prohibits advertising the name, manufacturing method, efficacy or performance until after approval or change approval has been obtained, or notification or change notification has been filed. In other words, the words veterinary quasi-drug have meaning within the range that went through approval or notification, and wording that claims a treatment or prevention effect beyond that range can conflict with these provisions.

How does the United States divide the oversight of external parasite products?

I did not confirm this time that the United States has a separate category named like Korea's veterinary quasi-drugs. What is confirmed in the U.S. materials opened is the division between agencies around external parasite products, that is, flea and tick products. The U.S. Environmental Protection Agency (EPA) page "EPA's Regulation of Flea and Tick Products" explains that such products applied to animals are divided by whether the chemical is absorbed systemically into the bloodstream or stays on the skin. If absorbed, the product is under the Food and Drug Administration (FDA); if it stays on the skin, it is under the EPA. The same page says that the EPA acknowledges that many of the topical products it regulates do not in fact stay on the skin, and that in February 2023 the 2 agencies therefore proposed a new approach.

The FDA page also describes a way to tell them apart by product label. According to the FDA guidance, a product approved by the FDA carries an approval statement with a 6-digit New Animal Drug Application number (NADA) or Abbreviated New Animal Drug Application number (ANADA), and a product registered by the EPA carries an EPA registration number (EPA Reg. No.). The FDA page "Modernizing FDA's and EPA's Approach…" says that stakeholder comments were taken at a public meeting on March 22, 2023, that it points to a white paper, and that there is no timeline to formalize the approach the white paper discussed. The page that says the white paper came out in February 2023 is the EPA page above. The date of check shown on that page was January 7, 2025.

Compared with Korea, the structure differs. Korea separates medicines and quasi-drugs within the Pharmaceutical Affairs Act, gathers animal use under the Ministry of Agriculture, Food and Rural Affairs, and then excludes from quasi-drugs, in Appendix Table 1, item 2 of the notice, external parasite preparations that are absorbed into the body and act there. In place of an agency division like the Pharmaceutical Affairs Act, the United States has the agency that handles pesticides and the agency that handles animal drugs divide by whether the product is absorbed. This comparison is limited to what is written on the 3 pages opened, and other U.S. product groups and the latest state were not confirmed.

What an owner can check in front of a product

This list is not guidance on choosing a product but an organized set of items that can be checked under the system from the package and the approval details. Each item rests on the articles confirmed above.

  • Check whether the words veterinary quasi-drug appear on the package or accompanying document, distinguishable from other text (Handling Rules Article 42, paragraph 1).
  • Check whether the efficacy and effects and the precautions are stated on the package or accompanying document (Article 42, paragraph 2). Also check whether the stated efficacy matches a product group in the notice's list.
  • Tell from the package whether the product is registered as feed or is a veterinary quasi-drug. Appendix Table 1 of the notice says that nutritional supplements registered under the Control of Livestock and Fish Feed Act (사료관리법) and supplementary feed additives registered as supplementary feed are not regarded as quasi-drugs.
  • Check whether the business name and address of the manufacturer or importer, the manufacturing number and the use-by date are there. These are items Article 65, paragraph 1 of the Pharmaceutical Affairs Act has put on quasi-drug containers and packages, and for animal use Articles 42 and 43 of the Handling Rules set the labeling items further.
  • Check that the animal the product is for matches the package's description. The pets in the notice are dogs, cats, rabbits, ferrets, guinea pigs and hamsters, and ornamental or riding animals not kept for food.
  • If there is wording such as healing a disease or being guaranteed by a veterinarian, suspect that it runs into the limit on expression set by Article 68 of the Pharmaceutical Affairs Act.
  • If the classification of a product is uncertain, ask the manufacturer or the APQA. Article 3 of the notice sets a procedure for requesting a review of whether a product is a quasi-drug.

Reading the package label helps in working out a product's classification, but the system does not make the judgment that the product suits my pet's condition.

Common misunderstandings about veterinary quasi-drugs

The first misunderstanding is the idea that quasi-drug means a medicine one step weaker. The Pharmaceutical Affairs Act definition groups quasi-drugs as things whose action on the human body is weak or that do not act directly on it, and the Handling Rules describe them as things whose action on animals is slight or not direct. But this is a classification requirement, not a statement that assures either safety or effect. That documents needed for the review of safety and efficacy are submitted at product approval is confirmed in Article 5, paragraph 3 of the Handling Rules, but whether the result of that review means safety in every situation of use is not confirmed in the articles.

The second misunderstanding is the idea that all shampoos and deodorants are veterinary quasi-drugs. The notice lists medicated shampoos and cleansing shampoos in Appendix Tables 1 and 2 respectively, but what is listed is products that fall within those categories, and it does not mean every shampoo. The deodorants in Appendix Table 1 exclude perfumes applied directly to hair or skin, and the bathing products in Appendix Table 2 exclude cosmetic soap. Whether a product is in this category is checked from its approval or notification and its package labeling.

The third misunderstanding is the idea that a veterinary quasi-drug may also be used on people, or that a human quasi-drug may be used on animals. Article 85, paragraph 1 of the Pharmaceutical Affairs Act places medicines and similar items intended for animal use only under the separate jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries. This article does not cover how to use a human product on an animal, and I did not confirm a basis for doing so in the materials opened.

The fourth misunderstanding is the idea that once approved, any efficacy may be advertised. Article 68, paragraph 5 of the Pharmaceutical Affairs Act says advertising is allowed only after approval or notification, but paragraphs 1 to 3 separately block false and exaggerated advertising and suggestive methods.

When to see a veterinarian

Knowing the category of veterinary quasi-drugs does not tell you what your pet needs now. When your pet keeps scratching its eyes or ears or discharge increases, when the skin is red or fur falls out or a wound does not heal, or when bad breath worsens or it has trouble eating, do not try to solve it by switching cleaners or shampoos; have it seen at an animal hospital. If there is a product that was used for the same symptom, bringing a record of the package, the period of use and the amount helps the consultation.

If vomiting, diarrhea, drooling, lethargy, labored breathing, collapse or seizures appear after a product was applied or given, go straight to an animal hospital or one that can provide emergency care. In that case, which system the product belongs to does not matter, and bringing the package or container can be used to tell the hospital which ingredients the pet was exposed to and how much.

Disinfectant and insecticidal products can be touched by both owner and animal, so read the precautions on the package before use and keep children and other animals from contact. If it was swallowed or got into the eyes, contact an animal hospital right away. This article does not give directions for use or doses, and actual use must follow the veterinarian's instructions and the product's instruction sheet.

Frequently asked questions

Q How is a veterinary quasi-drug different from a veterinary drug?

Article 2, paragraph 1 of the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) defines veterinary drugs (item 1) and veterinary quasi-drugs (item 3) separately. Quasi-drugs are grouped as things whose action on animals is slight or not direct, among others, and the scope is set by public notice of the head of the APQA. Both go through approval or notification under the Pharmaceutical Affairs Act and the Handling Rules, but procedures such as the division between approval and notification differ.

Q What products are among the veterinary quasi-drugs listed in the public notice?

Appendix Table 1 of the notice lists disinfectants for animal disease prevention, pest control agents, preventive agents and repellents, pet preparations such as oral hygiene preparations, ear and eye cleaners and deodorants, teat dips, simple external preparations for body protection, oral nutritional supplements and herbal preparations, supplementary feed additives, semen extenders and external sprays. Appendix Table 2 lists hygiene articles such as bandages, gauze, masks and adhesive plasters, and bathing products such as cleansing shampoos and rinses.

Q Can a nutritional supplement also be a veterinary quasi-drug?

Appendix Table 1, item 6 of the notice lists nutritional supplements whose main ingredient is a vitamin, enzyme, probiotic or the like as oral preparations. But it carries a proviso that a product registered under the Control of Livestock and Fish Feed Act (사료관리법) is not regarded as a veterinary quasi-drug. You cannot tell from the name supplement alone, and you need to check on the package which system's labeling it carries.

Q What approval or notification does a veterinary quasi-drug go through?

Article 31, paragraph 4 of the Pharmaceutical Affairs Act (약사법) sets a manufacturing business notification and product approval or notification for each product, and Article 5 of the Handling Rules places quasi-drugs under Article 2, paragraph 1, item 3, sub-item (a) under manufacturing product approval and those under sub-item (b) under manufacturing product notification. For imports, Article 16 of the Handling Rules follows the same division, and an approval application requires a certificate of manufacture and a certificate of sale.

Q How can I tell from the package that something is a veterinary quasi-drug?

Article 42, paragraph 1 of the Handling Rules requires the words veterinary quasi-drug to be marked on the container or package and in the accompanying document, distinguishable from other text. Paragraph 2 requires the efficacy and effects, precautions, storage method and so on to be stated. If these words are not visible, it is advisable to ask the manufacturer or the APQA whether the product has received quasi-drug approval or notification.

Q If it is a veterinary quasi-drug, can it be advertised as healing a disease?

Article 68, paragraph 1 of the Pharmaceutical Affairs Act (약사법) prohibits false and exaggerated advertising of efficacy or performance, and paragraph 3 prohibits articles, photographs, designs and suggestive methods that hint at efficacy. Paragraph 5 says advertising is allowed only after approval or notification. Wording that claims treatment or prevention of disease beyond the approved or notified matters can conflict with these provisions.

Q In the United States, which agency oversees flea and tick products?

The EPA page explains that products whose ingredients are absorbed systemically into the bloodstream are under the FDA, and those that stay on the skin are under the EPA. The FDA explains that FDA-approved products carry an NADA or ANADA number on the label and EPA-registered products carry an EPA registration number. The FDA page says that the 2 agencies proposed a change in how they oversee these products in 2023 but that there is no timeline.

Limits and scope of this guide

This is an editorial draft that has not had specialist veterinary or pharmacist review. It cannot be used for choosing or using a product, for doses, or for judging whether to treat, and it does not suit an animal suspected of being ill. I could not open and confirm other laws that set the boundary with ordinary manufactured goods (chemical products), the provisions on where veterinary quasi-drugs are sold, the list of notified items announced under Article 5, paragraph 2, item 3 of the Handling Rules, the detailed standards on the Control of Livestock and Fish Feed Act side, or the Animal and Plant Quarantine Agency's civil petition guidance pages. The U.S. comparison is limited to the 3 pages opened and may differ from the current state.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Pharmaceutical Affairs Act, Articles 2 (items 4 and 7), 31 (paragraphs 4 and 6), 42, 65, 68 and 85 (paragraph 1) (약사법) ↗

    Used as the basis for the definitions of medicines and quasi-drugs, the special rule on jurisdiction over medicines and similar items for animals, approval and notification for manufacture and import, quasi-drug labeling, and the provisions prohibiting exaggerated advertising. The current text opened is in force from November 12, 2026 (Act No. 21692).

  2. Rules on the Handling of Veterinary Drugs, etc., Articles 2, 2-2, 5, 16, 42 and 43 (동물용 의약품등 취급규칙) ↗

    Used as the basis for the definition of veterinary quasi-drugs (sub-items (a) and (b)), the jurisdiction of the head of the APQA, the division between manufacturing product approval and notification, the import documents, and the package labeling provisions. The current text opened is in force from October 31, 2025 (Ordinance of the Ministry of Agriculture, Food and Rural Affairs No. 741).

  3. Regulation on the Scope and Designation of Veterinary Quasi-drugs (Animal and Plant Quarantine Agency Public Notice No. 2025-34, Appendix Tables 1 and 2) (동물용의약외품의 범위 및 지정 등에 관한 규정) ↗

    Used as the basis for the product groups in Appendix Tables 1 and 2 that describe the scope of veterinary quasi-drugs, the provisos excluding products registered under the Control of Livestock and Fish Feed Act, and the procedure for requesting a review of whether a product falls under the category (Article 3). In force from December 1, 2025.

  4. EPA's Regulation of Flea and Tick Products ↗

    Used as the basis for the explanation that the FDA and the EPA divide flea and tick products applied to animals by whether the ingredient is absorbed into the bloodstream or stays on the skin.

  5. How can I tell if a flea and tick product is approved by FDA as an animal drug or registered by EPA as a pesticide? ↗

    Used as the basis for the way to tell products apart by the NADA or ANADA number statement on FDA-approved products and the registration number on EPA-registered products.

  6. Modernizing FDA's and EPA's Approach to Oversight of Products for Animals Regulated as Pesticides or New Animal Drugs ↗

    Used as the basis for the 2023 white paper and public meeting of the 2 agencies and the statement that there is no timeline to formalize the change (date shown on the page: 2025-01-07).

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 5 Korean laws or notices. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.